Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Therapeutic Drug Monitoring|March 27, 2003
Sildenafil does not alter nelfinavir pharmacokineticsGöran Bratt, Lars Ståhle
Antimicrobial Agents and Chemotherapy|July 25, 2003
Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovirJan Lycke, Clas Malmeström, Lars Ståhle
Therapeutic Drug Monitoring|May 27, 2003
Unbound valproate fraction in plasma and subcutaneous microdialysate in steady state and after a single dose in humansMartin Lindberger, Torbjörn Tomson, Lars Ståhle
Therapeutic Drug Monitoring|November 27, 2002
Dosage of ribavirin in patients with hepatitis C should be based on renal function: a population pharmacokinetic analysisAnnette Bruchfeld, Karin Lindahl, Robert Schvarcz, et al.
Pharmacology & Toxicology|November 25, 2003
Effect of probenecid and quinidine on the transport of alovudine (3'-fluorothymidine) to the rat brain studied by microdialysisKarin Lindén, Lars Ståhle, Ewa Ljungdahl-Ståhle, et al.
Therapeutic Drug Monitoring|May 29, 2004
Efavirenz plasma concentrations in HIV-infected patients: inter- and intraindividual variability and clinical effectsLars Ståhle, Lars Moberg, Jan-Olof Svensson, et al.
European Journal of Clinical Pharmacology|June 26, 2009
Reexamining transaminase elevation in Phase I clinical trials: the importance of baseline and change from baselineZhaohui Cai, Anastasia M Christianson, Lars Ståhle, et al.
Somatosensory & Motor Research|July 6, 2016
Comparing sensibility for touch, cold, and warmth in different skin areasNanna de Rezende Strander, Lars Ståhle, Per T Hansson
European Journal of Clinical Pharmacology|November 5, 2013
Assessment of interaction potential of AZD2066 using in vitro metabolism tools, physiologically based pharmacokinetic modelling and in vivo cocktail dataAnna Nordmark, Anita Andersson, Pawel Baranczewski, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 5, 2003
Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiencyAnnette Bruchfeld, Karin Lindahl, Lars Ståhle, et al.
Pageof 4